"10.1371_journal.pone.0030502","plos one","2012-02-10T00:00:00Z","Jose A Crespo; Petra St√∂ckl; Florian Ueberall; Marcel Jenny; Alois Saria; Gerald Zernig","Experimental Psychiatry Unit, Department of General Psychiatry and Social Psychiatry, Innsbruck Medical University, Innsbruck, Austria; Innsbruck Biocentre, Division of Medical Biochemistry, Innsbruck Medical University, Innsbruck, Austria","Conceived and designed the experiments: JAC GZ. Performed the experiments: JAC PS MJ. Analyzed the data: JAC. Contributed reagents/materials/analysis tools: MJ FU AS. Wrote the paper: GZ.","Dr Gerald Zernig has received speakers or consultancy fees or unrestricted educational grants or support for the execution of scientific conferences from the following pharmaceutical companies (in alphabetical order) which are manufacturers of antidepressants, antipsychotics, analgesics, opioid substitution medications, and/or hypnotics: AlcaSynn, AstraZeneca, Bio-Rad, Bristol-Myers Squibb, Eli Lilly, Kwizda, Janssen, Lundbeck, Mundipharma, Novartis, Nycomed, Pfizer, and Wyeth. He has held compensated yet unrestricted lectures on problems of therapeutic drug monitoring (TDM) for (in alphabetical order) the following pharmaceutical companies: AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen, Lundbeck, and Pfizer. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","02","Jose A Crespo","JAC",6,TRUE,2,3,1,1,TRUE,TRUE,FALSE,0,NA,FALSE
